FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

400314006: Product containing paracetamol and phenyltoloxamine citrate and salicylamide (medicinal product)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    1773515018 Paracetamol + phenyltoloxamine citrate + salicylamide en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    1774801019 Acetaminophen + phenyltoloxamine citrate + salicylamide en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3490647016 Product containing paracetamol and phenyltoloxamine citrate and salicylamide (medicinal product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3494842017 Product containing acetaminophen and phenyltoloxamine citrate and salicylamide en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3494843010 Product containing paracetamol and phenyltoloxamine citrate and salicylamide en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Acetaminophen + phenyltoloxamine citrate + salicylamide est un(e) (attribut) Acetaminophen + phenyltoloxamine citrate false Inferred relationship Some
    Acetaminophen + phenyltoloxamine citrate + salicylamide est un(e) (attribut) Product containing salicylamide (medicinal product) false Inferred relationship Some
    Acetaminophen + phenyltoloxamine citrate + salicylamide a pour principe actif (attribut) Salicylamide false Inferred relationship Some
    Acetaminophen + phenyltoloxamine citrate + salicylamide a pour principe actif (attribut) Ethanolamine false Inferred relationship Some
    Acetaminophen + phenyltoloxamine citrate + salicylamide a pour principe actif (attribut) Acetaminophen false Inferred relationship Some
    Acetaminophen + phenyltoloxamine citrate + salicylamide a pour principe actif (attribut) Phenyltoloxamine (substance) false Inferred relationship Some
    Acetaminophen + phenyltoloxamine citrate + salicylamide a pour principe actif (attribut) Phenyltoloxamine citrate false Inferred relationship Some
    Acetaminophen + phenyltoloxamine citrate + salicylamide a pour principe actif (attribut) Cardiovascular agent (substance) false Inferred relationship Some

    Inbound Relationships Type Active Source Characteristic Refinability Group
    Product containing precisely paracetamol 300 milligram and phenyltoloxamine citrate 20 milligram and salicylamide 200 milligram/1 each conventional release oral capsule (clinical drug) est un(e) (attribut) False Acetaminophen + phenyltoloxamine citrate + salicylamide Inferred relationship Some
    Acetaminophen 300 mg and phenyltoloxamine citrate 20 mg and salicylamide 200 mg oral tablet est un(e) (attribut) False Acetaminophen + phenyltoloxamine citrate + salicylamide Inferred relationship Some

    Reference Sets

    Canada English language reference set (foundation metadata concept)

    Concept inactivation indicator reference set

    Description inactivation indicator reference set

    GB English

    US English

    Back to Start